IEThe Irish Times
FG TDs ask firm behind Friedreich’s ataxia drug to consider compassionate access scheme
Meeting held with representatives from Biogen, which makes drug Skyclarys
Open original article- Ledger record
- #168
- First seen
- 17 Aug 2026, 21:26 UTC
- Last checked
- 17 Aug 2026, 21:26 UTC
- Version history
- 1 version
- Current fingerprint
10347d0559cf...21edfe
01
Publisher layer
Recorded article metadata
- Publisher
- The Irish Times
- Country
- Ireland
- Source published
- 17 Aug 2026, 18:37 UTC
- Source updated
- No update timestamp supplied
- Byline
- Jack Horgan-Jones
- Section
- Not supplied
Source-supplied excerpt
Meeting held with representatives from Biogen, which makes drug Skyclarys
02
Change layer
Observed version timeline
-
1
FG TDs ask firm behind Friedreich’s ataxia drug to consider compassionate access scheme
Meeting held with representatives from Biogen, which makes drug Skyclarys
Changed fieldstitlebylinedescriptionTextcontentTextsourcePublishedAtsourceUpdatedAtsectionimageUrltags- Version SHA-256
10347d0559cf...21edfe- Capture SHA-256
ee9e7fd520ee...a09b45
03
Interpretation layer
Labels with declared origins
Not an adjudication.
Publisher categories are copied from source metadata. Machine signals report observable wording or format and do not determine truth, intent, ethics, or wrongdoing.
- machine content-type Reported news observable-rules-v1 / 70% rule confidence
04
Public response layer
Reception snapshots
No reviewed reception capture yet.
Comment counts and samples remain absent until a lawful, source-specific capture method is reviewed. Absence is recorded instead of estimated.
05
Evidence layer
Capture provenance
- Capture ID
- #3
- Observed
- 17 Aug 2026, 21:26 UTC
- HTTP result
- 200 / parsed
- Raw payload
- 678,773 bytes, private gzip evidence
- Collector
- news-ledger/0.1
- Public boundary
- metadata and excerpt